|
|
|
Approximately 80% of all patients with myeloma develop bone disease. Bone disease can cause the bones to become thinner and weaker (osteoporosis), and it can make holes appear in the bone (lytic lesions). In addition to bone disease, myeloma patients may develop a condition called hypercalcemia. Both myeloma bone disease and hypercalcemia can be treated with a group of drugs called bisphosphonates. |
|
|
|
|
Peter Gimsing, MD
Rigshospitalet, Copenhagen University
Copenhagen, Denmark
May 3-6, 2011
Paris, France |
|
|
|
![]()
|
An overview by IMF Scientific Advisor Phil Greipp |
|
|
|
![]()
|
An excellent overview by IMF Scientific Advisor Greg Mundy and Babatunde O. Oyajobi, MB, ChB, PhD |
|
|
|
![]()
|
IMFer Mike Katz and Dr. Paul Richardson discuss myeloma bone disease |
|
|
back
print
back to top